MannKind Corp. (MNKD)

[DownWithPumpers]

17 dollars would've been almost 7 billion dollars.

Are you claiming that Mannkind sold 65% of the profits for 150 million, and could've sold 100% for 7 billion?

Afrezza shouldn't be on the market. The FDA shouldn't allow non-inferiority trials. For a new drug to be approved it should have to prove that it's better than the alternatives.

You have a drug that's:
1. More expensive than the competition
2. Not better than the competition
3. Only for the handful of people who are afraid of needles.